None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pregnant women at term, in labour having singleton pregnancy with cephalic presentation, scheduled to undergo vaginal delivery 2. Pregnant women with packed cell volume of 30% and above 3. Pregnant women who voluntarily consented to participate in the study
Exclusion criteria
Exclusion criteria: 1. Multiple gestation 2. Pregnancy with co-existing uterine fibroids 3. Women undergoing instrumental delivery 4. Women with polyhydramnios 5. Pregnant women with coagulation disorders 6. Maternal medical conditions in pregnancy like pre-eclampsia, eclampsia 7. Women with hypersensitivity to the drugs to be administered ( oxytocin, misoprostol), or pregnant women with febrile illness 8. Women with traumatic PPH such as those with cervical laceration and perineal laceration 9. Grand multiparous women 10. Women with antepartum Haemorrhage 11. Women with scarred uteri ( From previous myomectomy or caesarean section)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be the incidence of primary postpartum hemorrhage (PPH). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes measure will include, mean postpartum blood loss, duration of third stage of labour, side effects of the drugs, need for additional uterotonics, blood transfusion and postpartum haemoglobin | — |
Countries
Nigeria
Contacts
Resident Doctor